The University of Southampton
University of Southampton Institutional Repository

National advisory panels for childhood Cancer in the UK: An evaluation of current practice and a best practice statement for the future.

National advisory panels for childhood Cancer in the UK: An evaluation of current practice and a best practice statement for the future.
National advisory panels for childhood Cancer in the UK: An evaluation of current practice and a best practice statement for the future.
Background
National advisory panels (NAPs) have been established for the care of children and young people (CYP) with cancer in the United Kingdom since 2011, with an increase in panel number in recent years. Their practice has not previously been reviewed; therefore, we sought to evaluate the role, practice and impact of six selected NAPs offering expertise in ependymoma, histiocytosis, leukaemia, neuroblastoma, renal tumours and sarcoma.

Procedure
This service evaluation used mixed methodology, including review of NAP documentation, semi-structured interviews with the NAP chairs and an analysis of the cases referred for discussion.

Results
Total 1110 referrals were analysed. Results demonstrated the significant scope and amount of work undertaken by the NAPs, largely testament to the commitment of the panel members. Specific roles fulfilled have been highlighted, and NAP recommendations have been shown to influence clinical decision-making and be implemented in the majority of cases. Despite widespread good practice, areas to address have been identified; these include clarity regarding NAP membership, consistency in recommendations, the consideration of holistic information to promote personalised management and the exploration of wider multidisciplinary team roles.

Conclusions
In the context of increasing demand and the escalating number of NAPs, it is timely to consider how service improvement can be facilitated. Best practice guidelines have been formulated as a product of this study, to promote a sustainable and effective model for NAPs. Review and benchmarking national panel performance against these guidelines will drive high standards of care going forward and they should be embedded as standard practice.
multidisciplinary team, national advisory panel, Sarcoma, Humans, Leukemia, Adolescent, United Kingdom, Neuroblastoma, Child
1545-5017
e30159
Brown, Sarah Kate
9ca200b1-bc3e-4a85-b8f8-d171c12b965a
Chowdhury, Tanzina
1ae221ff-fc65-4c1f-ab77-6e60e4f1b991
Collin, Matthew
1007a158-59e1-4575-8ec6-85e686d0bcc9
Grundy, Richard G.
d1b69b74-8aae-480f-88cc-d411b2ee90f2
Howell, Lisa
07190f41-5a65-474e-b8ec-fa6cc1ef572c
Ramanujachar, Ramya
9a27f52b-157d-4349-b255-a2990da1e986
Rees, Helen
90e5d60b-c89c-4560-a3e2-75151a44c4f0
Vora, Ajay
9bf6b2a0-56fc-4797-86ea-d7108280cefc
Gray, Juliet
12d5e17c-97bb-4d6d-8fc4-3914b730ed42
Bate, Jessica
98a38609-eb0a-4d1a-9288-cb8f69cc4f0a
Brown, Sarah Kate
9ca200b1-bc3e-4a85-b8f8-d171c12b965a
Chowdhury, Tanzina
1ae221ff-fc65-4c1f-ab77-6e60e4f1b991
Collin, Matthew
1007a158-59e1-4575-8ec6-85e686d0bcc9
Grundy, Richard G.
d1b69b74-8aae-480f-88cc-d411b2ee90f2
Howell, Lisa
07190f41-5a65-474e-b8ec-fa6cc1ef572c
Ramanujachar, Ramya
9a27f52b-157d-4349-b255-a2990da1e986
Rees, Helen
90e5d60b-c89c-4560-a3e2-75151a44c4f0
Vora, Ajay
9bf6b2a0-56fc-4797-86ea-d7108280cefc
Gray, Juliet
12d5e17c-97bb-4d6d-8fc4-3914b730ed42
Bate, Jessica
98a38609-eb0a-4d1a-9288-cb8f69cc4f0a

Brown, Sarah Kate, Chowdhury, Tanzina, Collin, Matthew, Grundy, Richard G., Howell, Lisa, Ramanujachar, Ramya, Rees, Helen, Vora, Ajay, Gray, Juliet and Bate, Jessica (2023) National advisory panels for childhood Cancer in the UK: An evaluation of current practice and a best practice statement for the future. Pediatric Blood and Cancer, 70 (3), e30159, [e30159]. (doi:10.1002/pbc.30159).

Record type: Article

Abstract

Background
National advisory panels (NAPs) have been established for the care of children and young people (CYP) with cancer in the United Kingdom since 2011, with an increase in panel number in recent years. Their practice has not previously been reviewed; therefore, we sought to evaluate the role, practice and impact of six selected NAPs offering expertise in ependymoma, histiocytosis, leukaemia, neuroblastoma, renal tumours and sarcoma.

Procedure
This service evaluation used mixed methodology, including review of NAP documentation, semi-structured interviews with the NAP chairs and an analysis of the cases referred for discussion.

Results
Total 1110 referrals were analysed. Results demonstrated the significant scope and amount of work undertaken by the NAPs, largely testament to the commitment of the panel members. Specific roles fulfilled have been highlighted, and NAP recommendations have been shown to influence clinical decision-making and be implemented in the majority of cases. Despite widespread good practice, areas to address have been identified; these include clarity regarding NAP membership, consistency in recommendations, the consideration of holistic information to promote personalised management and the exploration of wider multidisciplinary team roles.

Conclusions
In the context of increasing demand and the escalating number of NAPs, it is timely to consider how service improvement can be facilitated. Best practice guidelines have been formulated as a product of this study, to promote a sustainable and effective model for NAPs. Review and benchmarking national panel performance against these guidelines will drive high standards of care going forward and they should be embedded as standard practice.

Text
NAP_evaluation_paper_v8.0_revised (2) - Accepted Manuscript
Download (163kB)
Text
Pediatric Blood Cancer-2022 - Brown - Version of Record
Download (589kB)

More information

Accepted/In Press date: 4 November 2022
e-pub ahead of print date: 24 December 2022
Published date: 1 March 2023
Additional Information: Funding Information: Dr Johannes Visser, Department of Paediatric Oncology, Addenbrookes Hospital, Cambridge, UK The National Advisory Panel members for ependymoma, histiocytosis, leukaemia, neuroblastoma, renal tumours and sarcoma. Publisher Copyright: © 2022 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.
Keywords: multidisciplinary team, national advisory panel, Sarcoma, Humans, Leukemia, Adolescent, United Kingdom, Neuroblastoma, Child

Identifiers

Local EPrints ID: 472376
URI: http://eprints.soton.ac.uk/id/eprint/472376
ISSN: 1545-5017
PURE UUID: b7cd4a22-b2ca-433d-985c-edb966e6d0d9
ORCID for Juliet Gray: ORCID iD orcid.org/0000-0002-5652-4722
ORCID for Jessica Bate: ORCID iD orcid.org/0000-0003-4933-9497

Catalogue record

Date deposited: 02 Dec 2022 17:46
Last modified: 21 Aug 2025 05:07

Export record

Altmetrics

Contributors

Author: Sarah Kate Brown
Author: Tanzina Chowdhury
Author: Matthew Collin
Author: Richard G. Grundy
Author: Lisa Howell
Author: Ramya Ramanujachar
Author: Helen Rees
Author: Ajay Vora
Author: Juliet Gray ORCID iD
Author: Jessica Bate ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×